lose weight without semaglutide FDA Approves Oral Semaglutide: First GLP-1 Loss Pill Why Semaglutide Finally Works When

Manufacturer patient assistance programs (Novo Nordisk's NovoCare and Eli Lilly's Lilly Cares) offer income-based access to branded products at reduced cost

Bone health is also a concern with GLP-1 medications, especially for women in menopause who are already at risk for bone loss

How Tirzepatide Works Tirzepatide is the first medication that targets two hormones instead of one: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide)

FDA-approved uses of tirzepatide (Mounjaro and Zepbound): Mounjaro is an FDA-approved dual receptor agonist used to treat blood sugar levels in individuals with type 2 diabetes mellitus

No direct purchase option: You must go through third-party telehealth providers, adding markup costs and reducing transparency